Sector Gamma As Clovis Oncology, Inc. Transaction History

Sector Gamma As

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$4.13 - $6.41 $648,281 - $1.01 Million	-156,969 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$4.82 - $7.72 $945,279 - $1.51 Million	-196,116 Reduced 55.54%	156,969 $915,000
Q2 2020 Aug 07, 2020	SELL	$5.69 - $9.69 $130,870 - $222,870	-23,000 Reduced 6.12%	353,085 $2.38 Million
Q1 2020 May 11, 2020	SELL	$3.77 - $11.0 $122,675 - $357,940	-32,540 Reduced 7.96%	376,085 $2.39 Million
Q4 2019 Feb 12, 2020	SELL	$3.0 - $16.43 $68,400 - $374,604	-22,800 Reduced 5.28%	408,625 $4.26 Million
Q2 2019 Jul 31, 2019	BUY	$12.81 - $25.67 $661,610 - $1.33 Million	51,648 Added 13.6%	431,425 $6.42 Million
Q1 2019 May 13, 2019	BUY	$17.66 - $30.28 $780,572 - $1.34 Million	44,200 Added 13.17%	379,777 $9.43 Million
Q4 2018 Feb 12, 2019	BUY	$11.63 - $32.67 $1.74 Million - $4.9 Million	150,000 Added 80.83%	335,577 $6.03 Million
Q3 2018 Nov 15, 2018	BUY	$29.37 - $49.48 $2.36 Million - $3.98 Million	80,486 Added 76.59%	185,577 $5.45 Million
Q3 2018 Nov 08, 2018	SELL	$29.37 - $49.48 $2.02 Million - $3.4 Million	-68,801 Reduced 39.57%	105,091 $3.09 Million
Q2 2018 Aug 02, 2018	BUY	$42.06 - $62.4 $2.1 Million - $3.12 Million	50,000 Added 40.36%	173,892 $7.91 Million
Q1 2018 May 09, 2018	SELL	$50.12 - $67.72 $1.36 Million - $1.84 Million	-27,100 Reduced 17.95%	123,892 $6.54 Million
Q4 2017 Feb 12, 2018	BUY	$57.69 - $84.58 $167,301 - $245,282	2,900 Added 1.96%	150,992 $10.3 Million
Q3 2017 Nov 07, 2017	BUY	$67.17 - $84.81 $9.95 Million - $12.6 Million	148,092	148,092 $12.2 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

Stay updated on Sector Gamma As with notifications on news.